Skip to main content

Juan José Palmí Perales

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Juan José Palmí Perales

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Deborah Pareto Onghena

Deborah Pareto Onghena

Head of group
Neuroradiology
Read more
Olga Maisterra Santos

Olga Maisterra Santos

Senior researcher
Neurovascular Diseases
Read more
Laura Doménech Moral

Laura Doménech Moral

Main researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Joan Joseph Munné

Joan Joseph Munné

Main researcher
Microbiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.